{"id":"W4388048272","doi":"10.1136/jitc-2023-sitc2023.0766","title":"766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Nivolumab; Oncolytic virus; Internal medicine; Pharmacokinetics; Gastroenterology; Refractory (planetary science); Pancreatic cancer; Adverse effect; Cancer; Oncology; Urology; Pharmacology; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001221274,0.0001561352,0.0002907446,0.00007780593,0.00005618716,0.0000184257,0.0001274835,0.0001054693,0.000001846837],"category_scores_gemma":[0.0004801233,0.000107675,0.00003043139,0.0002944203,0.0003153007,0.00001172514,0.00007883116,0.000160871,8.556515e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003309936,"about_ca_system_score_gemma":0.0003223995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001234242,"about_ca_topic_score_gemma":0.0007323331,"domain_scores_codex":[0.9982963,0.0002962856,0.0004290948,0.0004152003,0.0003111491,0.0002519625],"domain_scores_gemma":[0.9991898,0.00009106525,0.00009636866,0.0003374458,0.0001100904,0.0001752181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2300645,0.0007121649,0.7334768,0.0001376861,0.0001319299,0.000009481157,0.0005522766,0.003578611,0.01305795,0.00001041955,0.0001193871,0.01814881],"study_design_scores_gemma":[0.03042618,0.01089403,0.9492078,0.0001435097,0.00002520434,0.000001161637,0.00005255748,0.0001339873,0.008837946,0.00005748295,0.00007060102,0.000149575],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977489,0.0002037692,0.000002401771,0.0005747649,0.00004946378,0.001382341,0.00001478466,0.000008343606,0.00001530134],"genre_scores_gemma":[0.9994335,0.0001681943,0.00008084943,0.00008165961,0.00002977363,0.0001043902,0.00004976281,0.00002116664,0.00003072982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.215731,"threshold_uncertainty_score":0.4390859,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02569682065945692,"score_gpt":0.331014626253827,"score_spread":0.3053178055943701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}